ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001588217

Fakhry JAD

CIK 0001588217 Name as filed on the most recent filing

Filed as Fakhry JAD (15)

50 transaction lines · from 15 filings · filed 2014-11-13 to 2025-04-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-04-08 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 300 acquired 0.46 139.50 Form 4, filing 0001398344-25-007148
2025-04-04 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 4,538 acquired 0.52 2,367.02 Form 4, filing 0001398344-25-007148
2025-04-03 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 22,976 acquired 0.56 12,928.60 Form 4, filing 0001398344-25-007148
2025-04-02 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 917 acquired 0.58 531.86 Form 4, filing 0001398344-25-007148
2025-04-01 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 19,915 acquired 0.58 11,650.28 Form 4, filing 0001398344-25-007146
2025-03-31 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 21,654 acquired 0.59 12,775.86 Form 4, filing 0001398344-25-007146
2025-03-28 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 49,400 acquired 0.61 30,252.56 Form 4, filing 0001398344-25-007146
2025-03-27 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 18,504 acquired 0.62 11,379.96 Form 4, filing 0001398344-25-007146
2025-03-27 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 600 acquired 0.61 365.40 Form 4, filing 0001398344-25-007146
2025-03-26 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 13,292 acquired 0.61 8,094.83 Form 4, filing 0001398344-25-007146
2025-03-25 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 22,635 acquired 0.61 13,807.35 Form 4, filing 0001398344-25-007144
2025-03-24 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 100 acquired 0.60 60.50 Form 4, filing 0001398344-25-007144
2025-03-21 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 6,372 acquired 0.60 3,855.06 Form 4, filing 0001398344-25-007144
2025-03-20 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 5,320 acquired 0.61 3,271.27 Form 4, filing 0001398344-25-007144
2025-03-19 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 1,500 acquired 0.60 903.75 Form 4, filing 0001398344-25-007144
2025-03-18 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 10,000 acquired 0.63 6,300.00 Form 4, filing 0001398344-25-007141
2025-03-18 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 14,000 acquired 0.63 8,820.00 Form 4, filing 0001398344-25-007144
2025-03-14 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 25,511 acquired 0.63 16,071.93 Form 4, filing 0001398344-25-007141
2025-03-13 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 34 acquired 0.64 21.59 Form 4, filing 0001398344-25-007141
2025-03-12 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 11,837 acquired 0.62 7,369.72 Form 4, filing 0001398344-25-007141
2025-03-11 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 2,148 acquired 0.58 1,245.84 Form 4, filing 0001398344-25-007141
2025-03-10 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 14,645 acquired 0.58 8,494.10 Form 4, filing 0001398344-25-007141
2025-03-07 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 102 acquired 0.55 56.10 Form 4, filing 0001398344-25-007139
2025-03-04 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 4,000 acquired 0.58 2,313.60 Form 4, filing 0001398344-25-007139
2025-02-28 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 13,108 acquired 0.60 7,891.02 Form 4, filing 0001398344-25-007139
2025-02-27 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 385 acquired 0.61 234.85 Form 4, filing 0001398344-25-007139
2025-02-26 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 6,302 acquired 0.61 3,844.22 Form 4, filing 0001398344-25-007139
2025-02-25 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 25,033 acquired 0.62 15,517.96 Form 4, filing 0001398344-25-007139
2025-02-24 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 450 acquired 0.62 279.00 Form 4, filing 0001398344-25-007136
2025-02-20 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 1,836 acquired 0.63 1,156.68 Form 4, filing 0001398344-25-007136
2025-02-19 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 49,664 acquired 0.67 33,349.38 Form 4, filing 0001398344-25-007136
2025-02-18 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 3,222 acquired 0.66 2,126.52 Form 4, filing 0001398344-25-007136
2025-02-04 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 26,718 acquired 0.64 16,965.93 Form 4, filing 0001398344-25-007136
2025-02-03 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 2,597 acquired 0.64 1,649.10 Form 4, filing 0001398344-25-007136
2025-01-31 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 70,685 acquired 0.65 45,825.09 Form 4, filing 0001398344-25-007133
2025-01-27 NovaBay Pharmaceuticals, Inc.
NBY 		P, Open-market purchase 31,703 acquired 0.69 21,875.07 Form 4, filing 0001398344-25-007133
2021-08-30 Gyrodyne, LLC
GYRO 		S, Open-market sale 6,200 disposed 13.00 80,600.00 Form 4, filing 0001104659-21-111223
2021-08-27 Gyrodyne, LLC
GYRO 		S, Open-market sale 30,000 disposed 13.04 391,200.00 Form 4, filing 0001104659-21-111223
2016-05-17 Swisher Hygiene Inc.
SWSH 		P, Open-market purchase 18,961 acquired 0.92 17,444.12 Form 4, filing 0001144204-16-103183
2016-05-16 Swisher Hygiene Inc.
SWSH 		P, Open-market purchase 38,900 acquired 0.94 36,566.00 Form 4, filing 0001144204-16-103157
2016-05-16 Swisher Hygiene Inc.
SWSH 		S, Open-market sale 38,900 acquired 0.94 36,566.00 Form 4, filing 0001144204-16-103040
2016-05-13 Swisher Hygiene Inc.
SWSH 		P, Open-market purchase 65,150 acquired 0.92 59,938.00 Form 4, filing 0001144204-16-103157
2016-05-13 Swisher Hygiene Inc.
SWSH 		S, Open-market sale 65,150 acquired 0.92 59,938.00 Form 4, filing 0001144204-16-103040
2016-05-09 Swisher Hygiene Inc.
SWSH 		S, Open-market sale 146,000 acquired 0.94 137,240.00 Form 4, filing 0001144204-16-099862
2016-05-06 Swisher Hygiene Inc.
SWSH 		S, Open-market sale 160,000 acquired 0.95 152,000.00 Form 4, filing 0001144204-16-099862
2015-08-03 Sycamore Networks Inc
SCMR 		S, Open-market sale 4,067,126 disposed 0.42 1,728,528.55 Form 4, filing 0001144204-15-046413
2015-07-01 Emrise Corp
EMRI 		P, Open-market purchase 25,000 acquired 1.11 27,750.00 Form 4, filing 0001144204-15-040886
2015-06-30 Emrise Corp
EMRI 		P, Open-market purchase 138,351 acquired 1.12 154,953.12 Form 4, filing 0001144204-15-040886
2014-10-10 Sycamore Networks Inc
SCMR 		P, Open-market purchase 823,343 acquired 0.35 286,111.69 Form 4, filing 0001144204-14-067652
2014-07-16 Sycamore Networks Inc
SCMR 		P, Open-market purchase 96,000 acquired 0.52 49,920.00 Form 4, filing 0001144204-14-067652

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. FAKHRY JAD, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001588217

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.